Aspira Women's Health Inc.
Aspira Women's Health Inc. (AWH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
awh · stock forecast · 5 analysts (3M) · FMP · updated Feb 12, 2026
Analyst Rating & Consensus
Based on 5 Wall Street analysts in the past 3 months
Buy
5 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$3.30
Consensus
$3.30
+3924.4% upside
Low
$3.30
Median: $3.3 · Last Close: $0.08
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.08 | ↑ 0.00% |
1-day model range: $0.08–$0.08. Peak: $0.08 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AWH · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-08-14 | Alliance Global Partners | Maintains | Buy→Buy |
| 2024-04-10 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2024-04-01 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-09-26 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-05-17 | Cantor Fitzgerald | Maintains | Neutral→Neutral |
| 2023-01-20 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2021-03-29 | Truist Securities | Maintains | Buy→Buy |
| 2021-01-29 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2020-10-30 | William Blair | Maintains | Outperform→Outperform |
| 2017-01-06 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
Wall Street analysts have recently issued updated ratings on Aspira Women's Health Inc. (AWH) stock. Of the recent 10 rating actions, 0 were upgrades and 2 were downgrades. 5 analysts currently cover AWH.
Analyst Recommendation Trends
AWH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$9M
↓ 61.7% YoY
Revenue Next Year
$11M
↑ 22.3% YoY
EPS This Year
$-1.46
EPS Next Year
$-1.20
↓ 17.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast AWH EPS of $-1.46 for the current fiscal year, based on estimates from 1 analysts. The AWH revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AWH stock forecast is supported by two independent data sources: analyst consensus ratings from 5 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AWH price target is $3.30 (+3924.4% upside), with an analyst consensus of Buy.
The AWH short-term stock prediction for tomorrow is $0.08 (+0.00%).
Aspira Women's Health Inc. trades on NASDAQ under the ticker AWH. The AWH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
AWH forecast · 8 questionsAccording to 5 Wall Street analysts, the average 12-month AWH price target is $3.30, with a high forecast of $3.30 and a low of $3.30. The median price target is shown in the chart above when available. This implies +3924.4% potential upside from the current price of $0.08.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.